FDA Has Known about Vaccine Shedding for Years and Has Even Issued Guidance on How to Evaluate the Risk

Rhoda Wilson

In 2015 the US Food and Drug Administration (“FDA”) issued guidance on how to conduct shedding studies during the preclinical and clinical development of virus or bacteria-based gene therapy products. Shedding, as described by the FDA, is the excretion or release of a product from a vaccinated person’s body. The shed gene therapy product may be infectious and so raises safety concerns “related to the risk of transmission to untreated individuals.”

Various studies and documents, including a study by Pfizer, indicate vaccine shedding and transmission are occurring.

A University of Colorado study published in May provided evidence “for a new mechanism by which herd immunity may be manifested – the aerosol transfer of antibodies between immune and non-immune hosts.”

… Additionally, in February 2022, Dr. Philippe van Welbergen demonstrated that “shards” of graphene are being transmitted from vaccinated to unvaccinated people.

Latest articles

Rebecca Park Totilo Essential Oils for radiation sickness, biological warfare, chemical warfare...
Rebecca Park Totilo Living Grand Convention that inflammation is a signal that...
Maharishi Ayurveda Products International, Inc. Radiation—energy that travels through the atmosphere as...
Alan V. Schmukler There are numerous substances which are rumored to offer...
World Health Organization This document describes protocols and practices for ensuring the...

Thank you!

Thank you for your membership application. As soon as your payment has been received your membership will be activated and you will be informed via email.

Thank you.

Thank you!

The form has been submitted successfully!